Effects of M-current modulators on the excitability of immature rat spinal sensory and motor neurones

European Journal of Neuroscience

Volumn 22, Issue 12, 2005, Pages 3091-3098

  Rivera Arconada, I ^a   Lopez Garcia, J A ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

10, 10 bis(4 pyridinylmethyl) 9(10H) anthracenone; Dorsal horn neurones; KCNQ; Retigabine; Spinal cord

Indexed keywords

10,10 BIS(2 FLUORO 4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; 10,10 BIS(4 PYRIDINYLMETHYL) 9(10H) ANTHRACENONE; CALCIUM; RETIGABINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CELL MATURATION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HYPERPOLARIZATION; LONG TERM POTENTIATION; MALE; MEDICAL ASSESSMENT; MOTONEURON NUCLEUS; NERVE CELL EXCITABILITY; NERVE TRANSECTION; NEUROMODULATION; NOCICEPTION; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL CORD DORSAL HORN; SPINAL CORD TRANSSECTION; SYNAPTIC TRANSMISSION;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTHRACENES; ANTICONVULSANTS; CARBAMATES; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; FEMALE; MALE; MEMBRANE POTENTIALS; MOTOR NEURONS; NEURONS, AFFERENT; PHENYLENEDIAMINES; POTASSIUM CHANNELS, VOLTAGE-GATED; RATS; REACTION TIME; SPINAL CORD; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 29344437462     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04507.x     Document Type: Article

References (30)

1. Aiken, S.P., Lampe, B.J., Murphy, P.A. & Brown, B.S. (1995) Reduction of spike frequency adaptation and blockade of M-current in rat CA1 pyramidal neurones by linopirdine (DuP 996), a neurotransmitter release enhancer. Br. J. Pharmacol., 115, 1163-1168.
2. Alaburda, A., Perrier, J.F. & Hounsgaard, J. (2002) An M-like outward current regulates the excitability of spinal motoneurones in the adult turtle. J. Physiol., 540, 875-881.
3. Blackburn-Munro, G. & Jensen, B.S. (2003) The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur. J. Pharmacol., 460, 109-116.
4. Brown, D. A. & Adams, P.R. (1980) Muscarinic suppression of a novel voltage-sensitive K+ current in a vertebrate neurone. Nature, 283, 673-676.
5. Dedek, K., Kunath, B., Kananura, C., Reuner, U., Jentsch, T.J. & Steinlein, O.K. (2001) Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc. Natl Acad. Sci. U.S.A., 98, 12 272-12 277.
6. Devaux, J.J., Kleopa, K.A., Cooper, B.C. & Scherer, S.S. (2004) KCNQ2 is a nodal K+ channel. J. Neurosci., 24, 1236-1244.
7. Dost, R., Rostock, A. & Rundfeldt, C. (2004) The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation. Naunyn Schmiedebergs Arch. Pharmacol., 369, 382-390.
8. Hedo, G., Laird, J.M. & Lopez-Garcia, J.A. (1999) Time-course of spinal sensitization following carrageenan-induced inflammation in the young rat: a comparative electrophysiological and behavioural study in vitro and in vivo. Neuroscience, 92, 309-318.
9. Hetka, R., Rundfeldt, C., Heinemann, U. & Schmitz, D. (1999) Retigabine strongly reduces repetitive firing in rat entorhinal cortex. Eur. J. Pharmacol., 386, 165-171.
10. Huang, L.Y. (1987) Electrical properties of acutely isolated, identified rat spinal dorsal horn projection neurons. Neurosci. Lett., 82, 267-272.
11. Jentsch, T.J. (2000) Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci., 1, 21-30.
12. Kapetanovic, I.M., Yonekawa, W.D. & Kupferberg, H.J. (1995) The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro. Epilepsy Res., 22, 167-173.
13. Lopez-Garcia, J.A. & King, A.E. (1994) Membrane properties of physiologically classified rat dorsal horn neurons in vitro: correlation with cutaneous sensory afferent input. Eur. J. Neurosci., 6, 998-1007.
14. Lopez-Garcia, J.A. & Laird, J.M. (1998) Central antinociceptive effects of meloxicam on rat spinal cord in vitro. Neuroreport, 9, 647-651.
15. Murase, K. & Randic, M. (1983) Electrophysiological properties of rat spinal dorsal horn neurones in vitro: calcium-dependent action potentials. J. Physiol, 334, 141-153.
16. Nielsen, A.N., Mathiesen, C. & Blackburn-Munro, G. (2004) Pharmacological characterisation of acid-induced muscle allodynia in rats. Eur. J. Pharmacol., 487, 93-103.
17. Passmore, G.M., Selyanko, A.A., Mistry, M., Al-Qatari, M., Marsh, S.J., Matthews, E.A., Dickenson, A.M., Brown, T.A., Burbidge, S.A., Main, M. & Brown, D.A. (2003) KCNQ/M currents in sensory neurons: significance for pain therapy. J. Neurosci., 23, 7227-7236.
18. van Rijn, C.M. & Willems-van, B.E. (2003) Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex. Eur. J. Pharmacol., 464, 95-100.
19. Rivera-Arconada, I., Martinez-Gomez, J. & Lopez-Garcia, J.A. (2004) M-current modulators alter rat spinal nociceptive transmission: an electrophysiological study in vitro. Neuropharmacology, 46, 598-606.
20. Romero, M., Reboreda, A., Sanchez, E. & Lamas, J.A. (2004) Newly developed blockers of the M-current do not reduce spike frequency adaptation in cultured mouse sympathetic neurons. Eur. J. Neurosci., 19, 2693-2702.
21. Rundfeldt, C. (1997) The new anticonvulsant retigabine (D-23129) acts as an opener of K+ channels in neuronal cells. Eur. J. Pharmacol., 336, 243-249.
22. Rundfeldt, C. & Netzer, R. (2000) Investigations into the mechanism of action of the new anticonvulsant retigabine. Interaction with GABAergic and glutamatergic neurotransmission and with voltage gated ion channels. Arzneimittelforschung, 50, 1063-1070.
23. Schenzer, A., Friedrich, T., Pusch, M., Saftig, P., Jentsch, T.J., Grotzinger, J. & Schwake, M. (2005) Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J. Neurosci., 25, 5051-5060.
24. Schroeder, B.C., Hechenberger, M., Weinreich, F. & Kubisch, C. (2000) KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J. Biol. Chem., 275, 24 089-24 095.
25. Selyanko, A.A., Hadley, J.K., Wood, I.C., Abogadie, F.C., Delmas, P., Buckley, N.J., London, B. & Brown, D.A. (1999) Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell. J. Neurosci., 19, 7742-7756.
26. Tatulian, L., Delmas, P., Abogadie, F.C. & Brown, D.A. (2001) Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci., 21, 5535-5545.
27. Wang, H.S., Pan, Z., Shi, W, Brown, B.S., Wymore, R.S., Cohen, I.S., Dixon, J.E. & McKinnon, D. (1998) KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science, 282, 1890-1893.
28. Wang, H.S., Brown, B.S., McKinnon, D. & Cohen, I.S. (2000) Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991. Mol. Pharmacol., 57, 1218-1223.
29. Wuttke, T.V., Seebohm, G., Bail, S., Maljevic, S. & Lerche, H. (2005) The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol. Pharmacol., 67, 1009-1017.
30. Yue, C. & Yaari, Y. (2004) KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons. J. Neurosci., 24, 4614-4624.